Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapy.
Pepijn W A ThomasTessa E H RömkensRachel L WestMaurice G V M RusselJeroen M JansenJette A van LintNaomi T JessurunFrank HoentjenPublished in: United European gastroenterology journal (2021)
IBD patients often report ADRs during biological therapy. We observed an important significant difference between the type and frequency of patient-reported ADRs versus HCP-reported ADRs, leading to an underestimation of more subjective ADRs and patients' ADR-related burden.